To investigate the mechanism underlying the drug resistance of ovarian cancer, the expression levels of BRCA1 were detected in platinum‐resistant and platinum‐sensitive ovarian cancer tissues. The gene discussed is BRCA1; the disease is ovarian carcinoma.